pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Legend Biotech Corp ($LEGN) · news · pharmadog
← back to Legend Biotech Corp
News mentioning $LEGN
42
stories
7d
10 companies hiring in New Jersey
biospace
8d
China has a clear shot to 2030 goals, though economic, cultural barriers remain
biospace
9d
BioSpace 2027 Best Places to Work shines light on most admired employers
biospace
12d
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
biospace
14d
The top 12 companies hiring in biopharma now
biospace
15d
6 potential blockbusters that could pave China’s path to 2030 ambitions
biospace
16d
Cell therapy investment grows as safety events rankle Big Pharma's CAR T autoimmune push
biospace
29d
Most new drugs are still too costly at launch, ICER says
biopharma dive
Sep 25, 26
Legend's five-year data suggests Carvykti could be a cure; Addex, Indivior split
endpoints
Sep 25, 26
J&J, Legend tout long-term survival benefits for Carvykti in multiple myeloma
biospace
Sep 23, 26
9 companies hiring in Pennsylvania now
biospace
Sep 18, 26
Legend names new CEO as Carvykti competition grows; Vertex makes a flurry of moves
endpoints
Sep 17, 26
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
fiercebiotech
Sep 17, 26
Trending: Top biopharma disciplines with jobs live now
biospace
Sep 17, 26
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
Sep 15, 26
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
Sep 8, 26
Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint
fiercebiotech
Sep 3, 26
The hidden scale-out problem behind CAR-T’s growth
biopharma dive
Aug 19, 26
11 companies hiring in New Jersey
biospace
Aug 14, 26
After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
fiercebiotech
Aug 13, 26
Chutes & Ladders—Former Legend CEO lands at K2
fiercebiotech
Aug 11, 26
Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs
biopharma dive
Aug 11, 26
Ex-Legend chief Ying Huang becomes CEO of K2, eyes $250M Series A
endpoints
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Jul 30, 26
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
Jul 30, 26
J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B
biopharma dive
Jul 30, 26
J&J secures right to take the helm in up to $925M Sail CAR T pact
biospace
Jul 27, 26
FDA scientists question Capricor data; Legend CEO steps down
biopharma dive
Jul 27, 26
Legend CEO Ying Huang resigns; Carvykti chief named interim leader
endpoints
Jul 27, 26
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
← prev
page 1 of 2
next →